newsfilter
← Latest News
ACCESS Newswire·

NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo

SHELTON, CT / ACCESS Newswire / June 22, 2026 / NanoViricides, Inc. today announced that it has shipped the NV-387 Oral Gummies Drug Product for a Phase II Clinical Trial of